JP Morgan Chase
NRX

JP Morgan Chase’s NEPHROGENEX INC COM NRX Stock Holding History

JP Morgan Chase’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-31,536
Closed -$15K – 5195
2016
Q1 		$15K Hold
31,536
– – ﹤0.01% 4165
2015
Q4 		$50K Hold
31,536
– – ﹤0.01% 3918
2015
Q3 		$107K Buy
+31,536
New +$138K ﹤0.01% 3752

JP Morgan Chase's NRX Position: Q2 2016 in Review

JP Morgan Chase sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 31,536 shares — an estimated $15K sold.

JP Morgan Chase first reported a position in NRX in Q3 2015 and held it in 3 quarters. The position peaked at $107K in Q3 2015. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

  • JP Morgan Chase reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
  • JP Morgan Chase sold 31,536 NEPHROGENEX INC COM shares in Q2 2016, an estimated $15K.
  • JP Morgan Chase first reported a position in NEPHROGENEX INC COM in Q3 2015 and held it in 3 quarters.
  • JP Morgan Chase's NEPHROGENEX INC COM position peaked at $107K in Q3 2015.
  • 1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on JP Morgan Chase's 13F filing for Q2 2016, filed 8 Aug 2016.